Enorama Pharma AB OMXSTO:ERMA:
SUBSIDIARY INTENDS TO APPEAL FDA'S RTF DECISION
COMPANY IN CONTACT WITH FDA FOR CLARITY ON REGULATORY STATUS
ANALYZING FDA DECISION AND EVALUATING CONSEQUENCES
Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
Earlier from Enorama Pharma Ab
- Bulletin from the extraordinary general meeting in Enorama Pharma Ab (publ)
- Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln